XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
REVENUES:        
TOTAL REVENUES $ 553,311 $ 597,857 $ 1,671,270 $ 1,701,983
Cost of goods sold 369,391 411,461 1,102,982 1,179,167
Gross Profit 183,920 186,396 568,288 522,816
OPERATING EXPENSES:        
Selling, general and administrative 148,609 153,452 452,076 465,412
Research and development 20,870 23,105 62,933 69,538
Restructuring, strategic transaction and integration 7,160 14,365 30,527 61,795
Change in fair value of contingent earn-out (15,572) (4,059) (12,256) (31,253)
TOTAL OPERATING EXPENSES 161,067 186,863 533,280 565,492
INCOME (LOSS) FROM OPERATIONS 22,853 (467) 35,008 (42,676)
Interest Expense,net (24,175) (17,808) (70,811) (46,303)
OTHER EXPENSE, net (4,044) (3,032) (5,815) (3,983)
Loss Before Income Taxes (5,366) (21,307) (41,618) (92,962)
BENEFIT FOR INCOME TAXES 12,604 8,099 29,110 34,212
NET LOSS $ 7,238 $ (13,208) $ (12,508) $ (58,750)
NET LOSS PER SHARE        
Basic (in dollars per share) $ 0.30 $ (0.55) $ (0.52) $ (2.47)
Diluted (in dollars per share) $ 0.30 $ (0.55) $ (0.52) $ (2.47)
WEIGHTED AVERAGE NUMBER OF SHARES        
Basic (in shares) 24,132 23,908 24,075 23,828
Diluted (in shares) 24,368 23,908 24,075 23,828